The mechanisms of cachexia underlying muscle dysfunction in COPD

Journal of Applied Physiology

Volumn 114, Issue 9, 2013, Pages 1253-1262

  Remels, A H V ^a   Gosker, H R ^a   Langen, R C J ^a   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cachexia; COPD; Energy metabolism; Muscle mass regulation; Skeletal muscle

Indexed keywords

MUSCLE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENERGY METABOLISM; GLYCOLYSIS; HUMAN; METABOLISM; MUSCLE MASS REGULATION; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; REVIEW; SKELETAL MUSCLE;

CACHEXIA; COPD; ENERGY METABOLISM; MUSCLE MASS REGULATION; SKELETAL MUSCLE;

APOPTOSIS; CACHEXIA; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGENERATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878622287     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00790.2012     Document Type: Review

References (112)

1. Agusti A, Edwards LD, Rennard SI, Macnee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ, Celli B. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLos One 7:e37483, 2012.
2. Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59:483-487, 2004. (Pubitemid 38797520)
3. Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:485-489, 2002.
4. Ansari K, Keaney N, Taylor I, Burns G, Farrow M. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease. Postgrad Med J 88:372-376, 2012.
5. Baarends EM, Schols AM, Akkermans MA, Wouters EF. Decreased mechanical efficiency in clinically stable patients with COPD. Thorax 52:981-986, 1997. (Pubitemid 27514494)
6. Barreiro E, De La Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, Gea J. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:1116-1124, 2005. (Pubitemid 40663723)
7. Barreiro E, Ferrer D, Sanchez F, Minguella J, Marin-Corral J, Martinez-Llorens J, Lloreta J, Gea J. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 111:808-817, 2011.
8. Barreiro E, Rabinovich R, Marin-Corral J, Barbera JA, Gea J, Roca J. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 64:13-19, 2009.
9. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63:100-107, 2008. (Pubitemid 351236469)
10. Bolton CE, Broekhuizen R, Ionescu AA, Nixon LS, Wouters EF, Shale DJ, Schols AM. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD. Thorax 62:109-114, 2007.
11. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119:285-298, 2004. (Pubitemid 39360909)
12. Calvert LD, Shelley R, Singh SJ, Greenhaff PL, Bankart J, Morgan MD, Steiner MC. Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:1090-1094, 2008. (Pubitemid 351717567)
13. Caron MA, Debigare R, Dekhuijzen PN, Maltais F. Comparative assessment of the quadriceps and the diaphragm in patients with COPD. J Appl Physiol 107:952-961, 2009.
14. Cerami A, Ikeda Y, Le Trang N, Hotez PJ, Beutler B. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). Immunol Lett 11:173-177, 1985. (Pubitemid 16213438)
15. Clanton TL, Levine S. Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? J Appl Physiol 107:324-335, 2009.
16. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc 58:321-328, 1999. (Pubitemid 29398115)
17. Coxson HO, Chan IH, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med 170:748-752, 2004. (Pubitemid 39298989)
18. Creutzberg EC, Schols AM, Weling-Scheepers CA, Buurman WA, Wouters EF. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:745-752, 2000. (Pubitemid 30171726)
19. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, Schols AM. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1239-1245, 2000.
20. Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F, Decramer M. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest 37:897-904, 2007. (Pubitemid 350029204)
21. Crul T, Testelmans D, Spruit MA, Troosters T, Gosselink R, Geeraerts I, Decramer M, Gayan-Ramirez G. Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD. Cell Physiol Biochem 25:491-500, 2010.
22. Debigare R, Cote CH, Maltais F. Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 7:84-90, 2010.
23. Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, Le Blanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 124:83-89, 2003. (Pubitemid 36851335)
24. Degens H, Swisher AK, Heijdra YF, Siu PM, Dekhuijzen PN, Alway SE. Apoptosis and Id2 expression in diaphragm and soleus muscle from the emphysematous hamster. Am J Physiol Regul Integr Comp Physiol 293:R135-R144, 2007. (Pubitemid 47092171)
25. Delample D, Durand F, Severac A, Belghith M, Mas E, Michel F, Cristol JP, Hayot M, Prefaut C. Implication of xanthine oxidase in muscle oxidative stress in COPD patients. Free Radic Res 42:807-814, 2008.
26. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453-1455, 1994. (Pubitemid 24356667)
27. Dias CM, Passaro CP, Cagido VR, Einicker-Lamas M, Lowe J, Negri EM, Capelozzi VL, Zin WA, Rocco PR. Effects of undernutrition on respiratory mechanics and lung parenchyma remodeling. J Appl Physiol 97:1888-1896, 2004. (Pubitemid 39426008)
28. Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR, Caron MA, Le Blanc P, Maltais F. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:261-269, 2007. (Pubitemid 47195876)
29. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, Shale DJ. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1414-1418, 2001. (Pubitemid 33124019)
30. Engelen MP, Deutz NE, Wouters EF, Schols AM. Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1488-1492, 2000.
31. Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7:1793-1797, 1994. (Pubitemid 24337350)
32. Engelen MP, Schols AM, Does JD, Deutz NE, Wouters EF. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med 161:98-103, 2000. (Pubitemid 30055909)
33. Engelen MP, Schols AM, Lamers RJ, Wouters EF. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 18:275-280, 1999. (Pubitemid 29527736)
34. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: a new definition. Clin Nutr 27:793-799, 2008.
35. Fermoselle C, Rabinovich R, Ausin P, Puig-Vilanova E, Coronell C, Sanchez F, Roca J, Gea J, Barreiro E. Does oxidative stress modulate limb muscle atrophy in severe copd patients? Eur Respir J 40:851-862, 2012.
36. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest 83:1614-1622, 1989. (Pubitemid 19124117)
37. Franssen FM, Sauerwein HP, Ackermans MT, Rutten EP, Wouters EF, Schols AM. Increased postabsorptive and exercise-induced wholebody glucose production in patients with chronic obstructive pulmonary disease. Metabolism 60:957-964, 2011.
38. Furutate R, Ishii T, Wakabayashi R, Motegi T, Yamada K, Gemma A, Kida K. Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 6:423-430, 2011.
39. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37:1974-1984, 2005. (Pubitemid 41206815)
40. Golgeli A, Ozesmi C, Suer C. Effect of acute starvation on rat diaphragm function. Jpn J Physiol 44:743-747, 1994.
41. Gosker HR, Engelen MP, Van Mameren H, Van Dijk PJ, Van Der Vusse GJ, Wouters EF, Schols AM. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 76:113-119, 2002. (Pubitemid 34686556)
42. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 30:73-79, 2007. (Pubitemid 47074009)
43. Gosker HR, Kubat B, Schaart G, Van Der Vusse GJ, Wouters EF, Schols AM. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 22:280-285, 2003. (Pubitemid 36986998)
44. Gosker HR, Van Mameren H, Van Dijk PJ, Engelen MP, Van Der Vusse GJ, Wouters EF, Schols AM. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 19:617-625, 2002. (Pubitemid 34285157)
45. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62:944-949, 2007. (Pubitemid 350084491)
46. Green HJ, Bombardier E, Burnett M, Iqbal S, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease. Am J Physiol Regul Integr Comp Physiol 295:R935-R941, 2008.
47. Green HJ, Burnett ME, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. J Appl Physiol 105:879-886, 2008.
48. Haegens A, Schols AM, Gorissen SH, Van Essen AL, Snepvangers F, Gray DA, Shoelson SE, Langen RC. NF-kappaB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy. Am J Physiol Lung Cell Mol Physiol 302:L103-L110, 2012.
49. Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58:30-38, 2009.
50. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel Moxham J, Polkey MI. A prospective study of decline in fat and skeletal muscle strength in chronic obstructive pulmonary Respir Res 8:25, 2007.
51. Ju CR, Chen RC. Serum myostatin levels and skeletal muscle in chronic obstructive pulmonary disease. Respir Med 106:2012.
52. Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Resting energy expenditure and protein turnover are increased with severe chronic obstructive pulmonary disease. Metabolism 1449-1455, 2011.
53. Kerr JS, Riley DJ, Lanza-Jacoby S, Berg RA, Spilker HC, Edelman NH. Nutritional emphysema in the rat. Influence depletion and impaired lung growth. Am Rev Respir Dis 131:1985.
54. Kurosaki H, Ishii T, Motohashi N, Motegi T, Yamada K, Jones RC, Kida K. Extent of emphysema on HRCT affects fat-free mass and fat mass in COPD. Intern Med 48:41-48
55. Kythreotis P, Kokkini A, Avgeropoulou S, Hadjioannou A, Anastasakou E, Rasidakis A, Bakakos P. Plasma leptin and insulingrowth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med 9:11, 2009.
56. Langen RC, Haegens A, Vernooy JH, Wouters EF, De Winther Carlsen H, Steele C, Shoelson SE, Schols AM. NF-kappa B is required for the transition of pulmonary inflammation atrophy. Am J Respir Cell Mol Biol 47:288-297, 2012.
57. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, EF, Janssen-Heininger YM. Muscle wasting and impaired regeneration in a murine model of chronic pulmonary inflammation. J Respir Cell Mol Biol 35:689-696, 2006. (Pubitemid 44901858)
58. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Physiol Cell Physiol 283:C714-C721, 2002. (Pubitemid 34920304)
59. Layec G, Haseler LJ, Hoff J, Richardson RS. Evidence that ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings. Am Regul Integr Comp Physiol 300:R1142-R1147, 2011.
60. Lemire BB, Debigare R, Dube A, Theriault ME, Cote CH, Mapk signalling in the quadriceps of patients with chronic obstructive pulmonary disease. J Appl Physiol 113:159-166, 2012.
61. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Moxham J, Hopkinson NS, Polkey MI, Kemp PR. Downregulation the serum response factor/miR-1 axis in the quadriceps of patients COPD. Thorax 67:26-34, 2012.
62. Lewis MI, Fournier M, Storer TW, Bhasin S, Porszasz J, Ren X, Casaburi R. Skeletal muscle adaptations to testosterone resistance training in men with COPD. J Appl Physiol 103:1299-1310
63. Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling skeletal muscle atrophy. J Mol Med 86:1113-1126, 2008.
64. Maltais F, Le Blanc P, Whittom F, Simard C, Marquis K, M, Breton MJ, Jobin J. Oxidative enzyme activities of lateralis muscle and the functional status in patients with COPD. 55:848-853, 2000.
65. Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, Hussain Gea J, Barreiro E. Oxidised proteins and superoxide anion in the diaphragm of severe COPD patients. Eur Respir J 33:1309 2009.
66. Mercken EM, Calvert LD, Singh SJ, Hageman GJ, Schols Steiner MC. Dichloroacetate modulates the oxidative stress and inflammatory response to exercise in COPD. Chest 136:744-751
67. Moldawer LL, Bistrian BR, Sobrado J, Blackburn GL. proteolysis in sepsis or trauma. N Engl J Med 309:494-495
68. Montes De Oca M, Torres SH, De Sanctis J, Mata A, Hernandez Talamo C. Skeletal muscle inflammation and nitric oxide with COPD. Eur Respir J 26:390-397, 2005. (Pubitemid 41264199)
69. Morrison WL, Gibson JN, Scrimgeour C, Rennie MJ. Muscle in emphysema. Clin Sci (Lond) 75:415-420, 1988.
70. Nguyen T, Shrager J, Kaiser L, Mei L, Daood M, Watchko Rubinstein N, Levine S. Developmental myosin heavy chains adult human diaphragm: coexpression patterns and effect of Appl Physiol 88:1446-1456, 2000.
71. Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations Chest 139:165-173, 2011.
72. Picard M, Godin R, Sinnreich M, Baril J, Bourbeau J, Perrault H, Taivassalo T, Burelle Y. The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? Am J Respir Crit Care Med 178:1040-1047, 2008.
73. Piehl-Aulin K, Jones I, Lindvall B, Magnuson A, Abdel-Halim SM. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease. Respiration 78:191-196, 2009.
74. Plant PJ, Brooks D, Faughnan M, Bayley T, Bain J, Singer L, Correa J, Pearce D, Binnie M, Batt J. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 42:461-471, 2010.
75. Pouw EM, Ten Velde GP, Croonen BH, Kester AD, Schols AM, Wouters EF. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr 19:95-99, 2000. (Pubitemid 30316022)
76. Powers SK, Smuder AJ, Criswell DS. Mechanistic links between oxidative stress and disuse muscle atrophy. Antioxid Redox Signal 15:2519-2528, 2011.
77. Puente-Maestu L, Tejedor A, Lazaro A, De Miguel J, Alvarez-Sala L, Gonzalez-Aragoneses F, Simon C, Agusti A. Site of mitochondrial ROS production in skeletal muscle of copd and its relationship with exercise oxidative stress. Am J Respir Cell Mol Biol 47:358-362, 2012.
78. Rabinovich RA, Ardite E, Mayer AM, Polo MF, Vilaro J, Argiles JM, Roca J. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 73:757-761, 2006. (Pubitemid 44795921)
79. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, Gonzalez De Suso JM, Vilaro J, Barbera JA, Polo MF, Argiles JM, Fernandez-Checa JC, Roca J. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1114-1118, 2001. (Pubitemid 33052236)
80. Rabinovich RA, Bastos R, Ardite E, Llinas L, Orozco-Levi M, Gea J, Vilaro J, Barbera JA, Rodriguez-Roisin R, Fernandez-Checa JC, Roca J. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 29:643-650, 2007. (Pubitemid 46554612)
81. Reid MB, Li YP. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand 171:225-232, 2001. (Pubitemid 32823790)
82. Reid MB, Li YP. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2:269-272, 2001. (Pubitemid 34189649)
83. Remels AH, Gosker HR, Schrauwen P, Hommelberg PP, Sliwinski P, Polkey M, Galdiz J, Wouters EF, Langen RC, Schols AM. TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J 24:5052-5062, 2010.
84. Remels AH, Schrauwen P, Broekhuizen R, Willems J, Kersten S, Gosker HR, Schols AM. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J 30:245-252, 2007. (Pubitemid 47194177)
85. Renvall MJ, Friedman P, Ramsdell JW. Predictors of body mass index in patients with moderate to severe emphysema. Copd 6:432-436, 2009.
86. 2 with small muscle mass exercise. Am J Respir Crit Care Med 169:89-96, 2004. (Pubitemid 38233894)
87. Riddoch-Contreras J, George T, Natanek SA, Marsh GS, Hopkinson NS, Tal-Singer R, Kemp P, Polkey MI. p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease. Copd 9:142-150, 2012.
88. Rutten EP, Franssen FM, Engelen MP, Wouters EF, Deutz NE, Schols AM. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr 83:829-834, 2006. (Pubitemid 44713147)
89. Saey D, Lemire BB, Gagnon P, Bombardier E, Tupling AR, Debigare R, Cote CH, Maltais F. Quadriceps metabolism during constant workrate cycling exercise in chronic obstructive pulmonary disease. J Appl Physiol 110:116-124, 2011.
90. Satta A, Migliori GB, Spanevello A, Neri M, Bottinelli R, Canepari M, Pellegrino MA, Reggiani C. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 10:2853-2860, 1997. (Pubitemid 28052800)
91. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82:53-59, 2005. (Pubitemid 41716377)
92. Serres I, Hayot M, Prefaut C, Mercier J. Skeletal muscle abnormalities in patients with COPD: contribution to exercise intolerance. Med Sci Sports Exerc 30:1019-1027, 1998. (Pubitemid 28317695)
93. Sharma R, Anker SD. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol 85:161-171, 2002.
94. Slinde F, Ellegard L, Gronberg AM, Larsson S, Rossander-Hulthen L. Total energy expenditure in underweight patients with severe chronic obstructive pulmonary disease living at home. Clin Nutr 22:159-165, 2003. (Pubitemid 36372460)
95. Stanojkovic I, Kotur-Stevuljevic J, Milenkovic B, Spasic S, Vujic T, Stefanovic A, Llic A, Ivanisevic J. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. Respir Med 105, Suppl 1:S31-37, 2011.
96. Steffen BT, Lees SJ, Booth FW. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. J Appl Physiol 105:1950-1958, 2008.
97. Thompson LV. Age-related muscle dysfunction. Exp Gerontol 44:106-111, 2009.
98. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167:1211-1227, 1988.
99. Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:1072-1077, 2010.
100. Ubhi BK, Riley JH, Shaw PA, Lomas DA, Tal-Singer R, Macnee W, Griffin JL, Connor SC. Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur Respir J 40:345-355, 2012.
101. Van Helvoort HA, Heijdra YF, De Boer RC, Swinkels A, Thijs HM, Dekhuijzen PN. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients. Chest 131:439-445, 2007. (Pubitemid 46280404)
102. Van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, Dekhuijzen PN. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 38:1543-1552, 2006. (Pubitemid 44373772)
103. Vermeeren MA, Wouters EF, Geraerts-Keeris AJ, Schols AM. Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. Clin Nutr 23:1184-1192, 2004. (Pubitemid 39243036)
104. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173:79-83, 2006. (Pubitemid 43069791)
105. Vivodtzev I, Debigare R, Gagnon P, Mainguy V, Saey D, Dube A, Pare ME, Belanger M, Maltais F. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest 141:716-725, 2012.
106. Vogiatzis I, Simoes DC, Stratakos G, Kourepini E, Terzis G, Manta P, Athanasopoulos D, Roussos C, Wagner PD, Zakynthinos S. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 36:301-310, 2010.
107. Vogiatzis I, Stratakos G, Simoes DC, Terzis G, Georgiadou O, Roussos C, Zakynthinos S. Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax 62:950-956, 2007. (Pubitemid 350084492)
108. Von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle 1:1-5, 2010.
109. Man DC, Natanek SA, Riddoch-Contreras J, Lewis A, Marsh GS, Kemp PR, Polkey MI. Quadriceps myostatin expression in COPD. Eur Respir J 36:686-688, 2010.
110. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 106:20405-20410, 2009.
111. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr 84:475-482, 2006. (Pubitemid 44713395)
112. Wust RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2:289-300, 2007. (Pubitemid 350110902)